Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
April 29, 2025
Calendar
CAR T-cell therapies have shown substantial efficacy in several haematological conditions and hold the potential for transformative benefits in certain other indications.
However, the complex journey to deliver CAR T-cell therapies to patients and associated operational and capacity-related needs can lead to suboptimal access to and use of these therapies.
Despite the launch of this modality in the U.S. in 2017 and in EU in 2018, barriers to patient access remain.
This webinar is intended to engage in dialogue multiple experts to identify key areas of focus to improve CAR T-cell therapy delivery and discuss an initial set of actions that could be tailored to specific country or regional needs.
Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
Unravel the complexities of cancer treatment with patient-level data-driven solutions.
Oncology Expertise that Fuels Your Development Success